PHS
NEO icon

PFM Health Sciences’s NeoGenomics NEO Stock Holding History

PFM Health Sciences’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2M Buy
1,784,552
+90,501
+5% +$952K 1.21% 26
2025
Q4 		$19.9M Sell
1,694,051
-514,479
-23% -$5.55M 1.99% 17
2025
Q3 		$17M Buy
2,208,530
+1,438,492
+187% +$10.1M 1.31% 23
2025
Q2 		$5.63M Buy
770,038
+184,657
+32% +$1.49M 0.48% 40
2025
Q1 		$5.56M Buy
+585,381
New +$7.31M 0.4% 42

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

PFM Health Sciences's NEO Position: Q1 2026 in Review

PFM Health Sciences increased its NeoGenomics (NEO) stake by 5.3% in Q1 2026, buying an estimated $952K and bringing the position to 1,784,552 shares worth $13.2M. The position accounts for 1.21% of the portfolio, ranked #26.

PFM Health Sciences first reported a position in NEO in Q1 2025 and has held it in 5 quarters since. The position peaked at $19.9M in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • PFM Health Sciences held 1,784,552 shares of NeoGenomics worth $13.2M as of Q1 2026.
  • PFM Health Sciences bought 90,501 NeoGenomics shares in Q1 2026, an estimated $952K.
  • NeoGenomics made up 1.21% of PFM Health Sciences's portfolio in Q1 2026, its #26 holding.
  • PFM Health Sciences first reported a position in NeoGenomics in Q1 2025 and has held it in 5 quarters since.
  • PFM Health Sciences's NeoGenomics position peaked at $19.9M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.